Literature DB >> 15458445

Static intra-access pressure ratio does not correlate with access blood flow.

Lawrence M Spergel1, Janet E Holland, Stephen Z Fadem, Charles J McAllister, Eileen J Peacock.   

Abstract

BACKGROUND: Access flow (Qa) measurement is recommended by Kidney Disease Outcomes Quality Initiative (K/DOQI) as the preferred method for access surveillance. Static intra-access pressure ratio (SIAPR) measurement is the second surveillance method of choice. The purpose of this prospective multicenter study was to investigate the relationship between SIAPR and Qa and to examine the premise upon which SIAPR surveillance is based-namely, that high SIAPR is a surrogate for low Qa associated with hemodynamically significant stenosis.
METHODS: SIAPR and Qa (HD01; Transonic Systems, Inc., Ithaca, NY, USA) were simultaneously measured monthly in 242 patients [146 prosthetic arteriovenous bridge grafts (AVG), 96 autogenous arteriovenous fistulas (AVF)] from three centers. SIAPR was measured according to the K/DOQI protocol.
RESULTS: There was no correlation between Qa and venous or arterial SIAPR in AVGs (R(2)= 0.0037 and R(2)= 0.006, respectively, N= 730), or in AVFs (R(2)= 0.0247 and R(2)= 0.0329, respectively, N= 431). Of the high SIAPR measurements in AVGs, 81% and 50% were associated with Qa > or =600 and Qa > or =1000 mL/min, respectively. Of the AVGs studied, 41% (60/146) had consistently high Qa > or =1000 mL/min. Seventy percent (42/60) of these high-Qa AVGs had at least two consecutive sessions with high SIAPR measurements, thereby meeting the K/DOQI SIAPR criteria for referral. In addition, 78% (14/18) of new AVGs with Qa > or =1000 mL/min, and 86% (6/7) of AVGs with the highest Qa (> or =2000 mL/min), had high SIAPR. As a result, these high-Qa AVGs, which represented the best functioning AVGs by K/DOQI Qa standards, were erroneously targeted for referral based on SIAPR measurements.
CONCLUSION: SIAPR does not correlate with Qa or discriminate between high and low Qa. Therefore, because the utility of SIAPR surveillance for detection of clinically significant stenosis depends on a correlation with Qa, the current use of absolute K/DOQI SIAPR thresholds for intervention based on the presumption that such thresholds are indicative of low Qa is not justified, and should be discontinued. Studies need to be done to examine the utility of SIAPR for trend analysis.

Entities:  

Mesh:

Year:  2004        PMID: 15458445     DOI: 10.1111/j.1523-1755.2004.00946.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  5 in total

1.  Association of Body Mass Index with Clinical Outcomes in Non-Dialysis-Dependent Chronic Kidney Disease: A Systematic Review and Meta-Analysis.

Authors:  Seyed-Foad Ahmadi; Golara Zahmatkesh; Emad Ahmadi; Elani Streja; Connie M Rhee; Daniel L Gillen; Luca De Nicola; Roberto Minutolo; Ana C Ricardo; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Cardiorenal Med       Date:  2015-10-16       Impact factor: 2.041

Review 2.  Hemodialysis vascular access monitoring: current concepts.

Authors:  Michael Allon; Michelle L Robbin
Journal:  Hemodial Int       Date:  2009-04       Impact factor: 1.812

3.  Effect of online haemodialysis vascular access flow evaluation and pre-emptive intervention on the frequency of access thrombosis.

Authors:  Edwin Wijnen; Frank M van der Sande; Jan H M Tordoir; Jeroen P Kooman; Karel M L Leunissen
Journal:  NDT Plus       Date:  2008-08-22

4.  Prediction of vascular access stenosis: Blood temperature monitoring with the Twister versus static intra-access pressure ratio.

Authors:  Yoo Jin Choi; Young-Ki Lee; Hayne Cho Park; Eun Yi Kim; Ajin Cho; Chaehoon Han; Sun Ryoung Choi; Hanmyun Kim; Eun-Jung Kim; Jong-Woo Yoon; Jung-Woo Noh
Journal:  PLoS One       Date:  2018-10-29       Impact factor: 3.240

5.  Static intra-access pressure ratio and cardiovascular events in patients undergoing haemodialysis.

Authors:  Hee Jung Jeon; Jieun Oh; Young-Ki Lee; Ajin Cho; Jong Woo Yoon; Hyunsuk Kim; Dong Ho Shin
Journal:  Sci Rep       Date:  2020-01-23       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.